Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial

Simon D. Roger; Sandrine Gaillard; Andreas Böck; Fernando Carrera; Kai‐Uwe Eckardt; David B. Van Wyck; Maureen Cronin; Yvonne Meier; Sylvain Larroque; Iain C. Macdougall; Simon D. Roger; Alastair Gilles; Randall Faull; Nigel D. Toussaint; Lawrence P. McMahon; Michael Suranyi; David W. Mudge; Brian Hutchison; Ashley Irish; Peter G. Kerr; Hemant Kulkarni; Grahame J. Elder; M Jardine; Karl Lhotta; Gert Mayer; Raymond Vanholder; Bart Maes; Pieter Evenepoel; Frederic Debellé; Michel Jadoul; Max Dratwa; Igor Macel; Milan Dunaj; Milan Kvapil; Petr Bucek; Jitka Řehořová; Aleš Hrubý; Václava Honová; L. Malanova; Martin Lucak; Dalibor Lecian; Martin Jirovec; Jiri Vlasak; Ivan Rychlík; Stanislav Šurel; Anne‐Lise Kamper; Ove Østergaard; G. Steffensen; Leïla Chénine; G. Choukroun; Philippe Zaoui; Christoph Wanner; Wolfgang Backs; Uwe Kraatz; Frank Dellanna; Klaus Busch; Tobias A. Marsen; Werner Seeger; Rainer P. Woitas; Nicholas Obermueller; Thomas Haak; Stephan Lueders; Frank Pistrosch; Eckhard Mueller; Peter R. Mertens; Werner Sutermer; Scott-Oliver Grebe; S. Hafezi-Rachti; Silke Roeser; Dimitrios Tsakiris; Dimitrios Memmos; Demetrios Vlachakos; Vassilis Vargemezis; Ioannis Stefanidis; Christos Syrganis; Polichronis Alivanis; Ioannis Papadakis; Nickolaos Papagalanis; Aimilios Andrikos; Dimitrios Goumenos; Kostas C. Siamopoulos; Charikelia Gouva; G Georgios Papadakis; Ioannis Boletis; Myrsini Tsimnadi-Spanoudaki; Dimitrios Stamatiades; Kyriaki Stamatelou; Spyridon Moutafis; Francesco Locatelli; Antonio Santoro; F Quarello; Giuseppe Remuzzi; Salvatore Coppola; Rosella Ferraro Mortellaro; A. Icardi; Giacomo Colussi; Franco Della Grotta; Luigi Lombardi

doi:10.1093/ndt/gfw264

Back

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial

Article 2017 en

Abstract

1 min read

These results further support the conclusion that correction of iron deficiency anemia with IV FCM is safe in patients with nondialysis-dependent CKD.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study

Keum Hwa Lee, Eujin Park, Hyun Jin Choi, Hee Gyung Kang, Il Soo Ha, Hae Il Cheong, Young Seo Park, Heeyeon Cho, Kyoung Hee Han, Seong Heon Kim, Min Hyun Cho, Joo Hoon Lee, Jae Il Shin

Article2013

Original Investigation Hemoglobin Stability in Patients With Anemia, CKD, and Type 2 Diabetes: An Analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) Placebo Arm

Hicham Skali, Julie Lin, Marc A. Pfeffer, Chaoyin Chen, Mark E. Cooper, John J.V. McMurray, Allen R. Nissenson, Giuseppe Remuzzi, Patrick S. Parfrey, Nairne Scott‐Douglas, Ajay Singh

Article2025

#1394 Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia

Finnian R. Mc Causland, B Claggett, Petr Jarolı́m, Martina M. McGrath, Emmanuel A. Burdmann, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Scott D Solomon, Marc A. Pfeffer

Article2025

EFFICACY OF ROXADUSTAT IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS WITH ANEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Lokman Hekim Tanrıverdi, Ayşe Uysal, Arzu Akyay, Yurday Öncül, Ahmet Sarıcı

Preprint2019

Cytokine Dependent Hematopoietic Cell Linker (CLNK) is Highly Elevated in Blood Transfusion Dependent Beta-Thalassemia Major Patients

Hussein Kadhem Al‐Hakeim, Hawraa Hussein Al-Mayali, Michael Maes